GuruFocus Premium Membership

Serving Intelligent Investors since 2004. Only 96 cents a day.

Free Trial

Free 7-day Trial
All Articles and Columns »

Weekly Top Insider Buys: D, SLE, CNP, CHTR, HGSI

March 27, 2011 | About:
guruek

gururk

7 followers
Weekly highlight of top insider buys: Dominion Resources (D), Sara Lee Corp. (SLE), CenterPoint Energy. (CNP),Charter Communications Inc. (CHTR), and Human Genome Sciences Inc. (HGSI).

Dominion Resources (D): Director Helen E Dragas Bought 14,584 Shares

Director of Dominion Resources, Helen E Dragas, bought 14,584 shares on 3/21/2011 at an average price of $44.54.

Dominion Resources is a producer of energy. Dominion has one of the larger British Thermal Unit production capability among integrated utilities in the northeast quadrant of the United States. Dominion Resources has a market cap of $25.87 billion; its shares were traded at around $44.54 with a P/E ratio of 13.3 and P/S ratio of 1.7. The dividend yield of Dominion Resources stocks is 4.4%. Dominion Resources had an annual average earnings growth of 3.9% over the past 10 years.

On January 28, Dominion announced unaudited reported earnings determined in accordance with Generally Accepted Accounting Principles (GAAP) for the 12 months ended Dec. 31, 2010, of $2.76 billion ($4.68 per share), compared with reported earnings of $1.29 billion ($2.17 per share) for the same period in 2009.Operating earnings for the 12 months ended Dec. 31, 2010, amounted to $1.97 billion ($3.34 per share), compared to operating earnings of $1.94 billion ($3.27 per share) for the same period in 2009. Operating earnings are defined as reported (GAAP) earnings adjusted for certain items.

Dominion Resources is in the portfolios of Kenneth Fisher, Mario Gabelli, James Barrow, and Dodge & Cox.

This month, Buy: Director William P Barr and Buy: Director Helen E Dragas bought shares of D stock. Buy: Director Robert H Jr Spilman and Sell: Director John W Harris sold shares in December

Sara Lee Corp. (SLE): Executive Chairman Jan Bennink Bought 128,400 Shares

Executive Chairman of Sara Lee Corp. (SLE) Jan Bennink bought 128,400 shares on 03/18/2011 at an average price of $17.84. Sara Lee Corporation is a global manufacturer and marketer of high-quality, brand-name products for consumers throughout the world. Sara Lee Corp. has a market cap of $11.1 billion; its shares were traded at around $17.84 with a P/E ratio of 23.8 and P/S ratio of 1. The dividend yield of Sara Lee Corp. stocks is 2.7%.

On Feb. 8, Sara Lee Corp. reported a 1.8% increase in second quarter fiscal 2011 adjusted net sales from continuing operations, driven by gains in the company’s two strategic growth businesses, North American Retail and International Beverage. On a reported basis net sales were essentially flat (-0.4%), due to the impact of a weaker euro. The company reported lower operating income and diluted earnings per share from continuing operations for the second quarter of fiscal 2011, primarily due to higher commodity costs net of pricing. Second quarter results compare to a very strong year-ago period, when decreasing commodity costs provided a benefit to the company. Sara Lee’s North American Fresh Bakery segment is now reported as a discontinued operation, following the agreement to sell the business to Grupo Bimbo.

Sara Lee Corp. is in the portfolios of John Hussman, Kenneth Fisher, Mario Gabelli, Jean-Marie Eveillard, Donald Yacktman, Goerge Soros, and Charles Brandes.

Last week, Buy: Executive Chairman Jan Bennink bought 128,400 shares of SLE stock. In February, Sell: Director Jeffrey W Ubben and Sell: EVP and CFO Mark A Garvey sold shares.

CenterPoint Energy. (CNP): Director Peter S Wareing Bought 10,000 Shares

Director of CenterPoint Energy Inc., Peter S Wareing, bought 10,000 shares on 3/23/2011 at an average price of $17.13.

CenterPoint Energy is a domestic energy delivery company that includes electricity transmission and distribution, natural gas distribution and sales, interstate pipeline and gathering operations. Centerpoint Energy Inc. has a market cap of $7.28 billion; its shares were traded at around $17.13 with a P/E ratio of 15.6 and P/S ratio of 0.8. The dividend yield of Centerpoint Energy Inc. stocks is 4.6%. Centerpoint Energy Inc. had an annual average earnings growth of 4.9% over the past 10 years.

On March 1, CenterPoint Energy Inc. reported net income of $124 million, or $0.29 per diluted share, for the fourth quarter of 2010 compared to $105 million, or $0.27 per diluted share, for the same period of 2009. Operating income for the fourth quarter of 2010 was $302 million compared to $299 million for the same period of 2009.

For the year ended December 31, 2010, net income was $442 million, or $1.07 per diluted share, compared to $372 million, or $1.01 per diluted share, for the same period of 2009. Operating income for the year ended December 31, 2010, was $1.25 billion compared to $1.12 billion for the same period of 2009.CenterPoint Energy Inc. is in the portfolios of James barrow, Brian Rogers, and George Soros.

This month, Buy: Director Peter S Wareing and Sell: Director Robert T Oconnell bought and sold shares of CNP stock respectively. Sell: Sr. VP and Group Pres Thomas R Standish, Sell: Director Robert T Oconnell, and Sell: EVP & CFO Gary L Whitlock sold shares in November.

Charter Communications Inc. (CHTR): Director John D Markley Jr Bought 23,900 Shares

Director of Charter Communications Inc., John D Markley, Jr bought 23,900 shares during the past week at an average price of $49.81.

Charter Communications, Inc. is a broadband communications company and the fourth-largest cable operator in the United States. Charter Communications Inc. has a market cap of $5.71 billion; its shares were traded at around $49.81 with and P/S ratio of 0.8.

On March 1, Charter Communications, Inc. reported financial and operating results for the three months and year ended December 31, 2010.

Compared with the prior year, revenues for the quarter ended December 31, 2010 grew 5.2% on a pro forma(1) basis and 4.3%on an actual basis. Revenues for the year ended December 31, 2010 increased 4.8% on a pro forma basis and 4.5% on an actualbasis. Fourth quarter adjusted EBITDAgrew 8.6% year-over-year on a pro forma basis and 8.1% on an actual basis. Net income attributable to Charter shareholders declined to a loss of $70 million in the fourth quarter of 2010 on a pro forma basis and $85 million on an actual basis. Adjusted EBITDA for 2010 increased to 4.5% on a pro forma basis and 4.3% on an actual basis. Net income attributable to Charter shareholders declined to a loss of $230 million for 2010 on a pro forma basis and $237 million on an actual basis.

This month, Buy: Director John D Markley Jr and Buy: Director Craig A Jacobson bought shares of CHTR stock. Buy: EVP/CFO Christopher L Winfrey bought 30,000 shares in November.

Human Genome Sciences Inc. (HGSI): Director Colin Goddard Bought 2,726 Shares

Director of Human Genome Sciences Inc., Colin Goddard, bought 2,726 shares on 3/22/2011 at an average price of $27.06.

Human Genome Sciences is a biopharmaceutical company with a pipeline of novel compounds in clinical development, including drugs to treat such diseases as hepatitis C, lupus, anthrax disease, cancer, rheumatoid arthritis and HIV/AIDS. Human Genome Sciences Inc. has a market cap of $5.11 billion; its shares were traded at around $27.06 with and P/S ratio of 32.5.

On February 24, Human Genome Sciences, Inc. announced financial results for the quarter and full year ended December 31, 2010. HGS reported revenues of $157.4 million for the year ended December 31, 2010, compared with revenues of $275.7 million for 2009. The company reported a net loss for 2010 of $233.2 million ($1.24 per share), compared with net income of $5.7 million ($0.04 per share) for 2009.

Human Genome Sciences Inc. is in the portfolio of George Soros.

Buy: CEO Thomas Watkins bought 60,000 shares of HGSI stock on 01/05/2011 at the average price of 24.16. Thomas Watkins owns at least 232,075 shares after this. The price of the stock has increased by 12% since.

Directors and Officers Recent Trades:

This month, Buy: Director Colin Goddard and Buy: Director Gregory Norden sold shares of HGSI. Sell: Director Maxine Gowen sold 7,926 shares this month. Sell: Sr. VP, Operations Curran Simpson sold 22,903 shares in October.

For the complete list of stocks that bought by their company executives, go to: Insider Buys.


Rating: 3.5/5 (4 votes)

Comments

juliarix
Juliarix - 3 years ago
If you have been recently diagnosed with positive, you may be upset and confused and think your sex life is over. However, it's not the end of the world, and it's not the end of your social life. You are not alone! Check positive-single. com. Many cities in the US and around the world have herpes/HIV/HPV social and support groups that you can join to meet others who are in the same situation.

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK